Lilly Boosts Weight-Loss Market Position with Zepbound Approval
Eli Lilly strengthens its weight-loss market position with the approval of Zepbound, complementing its existing drug, Mounjaro. Discover more about Lilly's strategic expansion.
Zepbound's approval adds to Lilly's portfolio alongside Mounjaro, strengthening its position in the weight-loss market.